Critical Analysis: Arch Therapeutics (OTCMKTS:ARTH) versus Profound Medical (NASDAQ:PROF)
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) and Profound Medical (NASDAQ:PROF – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends. Institutional & Insider Ownership 6.9% of Arch […]
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) and Profound Medical (NASDAQ:PROF – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends. Institutional & Insider Ownership 6.9% of Arch […]
-logo-1200x675.jpg&w=240&h=240&zc=2){kind=logo}